(Q42210137)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Evaluation of the inhibitory effects of miltefosine on the growth of Babesia and Theileria parasites (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Akram Salama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Davasorin Batadoj

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Tserendorj Munkhjargal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Madoka Ichikawa-Seki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Mohammad A Terkawi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Naoaki Yokoyama

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ikuo Igarashi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

23 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

published in

Veterinary Parasitology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

104-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24938827%20AND%20SRC:MED&resulttype=core&format=json

Apicoplast-targeting antibacterials inhibit the growth of Babesia parasites

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Inhibitory effect of terpene nerolidol on the growth of Babesia parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Inhibitory effects of (-)-epigallocatechin-3-gallate from green tea on the growth of Babesia parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Growth-inhibitory effect of heparin on Babesia parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Giardia lamblia: a new target for miltefosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Multiplex polymerase chain reaction based assay for the detection of Babesia bigemina, Babesia bovis and Anaplasma marginale DNA in bovine blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Phosphatidylcholine formation is the predominant lipid biosynthetic event in the hemoparasite Babesia bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

The phospholipid analogue hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Alkylphosphocholines: a new class of membrane-active anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Investigation into the immunological effects of miltefosine, a new anticancer agent under development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Genetic and antigenic characterization of Babesia bovis merozoite spherical body protein Bb-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis and the proliferation of HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Comparative genomic analysis and phylogenetic position of Theileria equi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Babesia microti, upstate New York

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Regulation of mammalian cell membrane biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Miltefosine enhances phagocytosis but decreases nitric oxide production by peritoneal macrophages of C57BL/6 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

In vitro responsiveness of Babesia bovis to imidocarb dipropionate and the selection of a drug-adapted line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Conditional mutagenesis of a novel choline kinase demonstrates plasticity of phosphatidylcholine biogenesis and gene expression in Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Chemotherapy against babesiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Anti-acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

A class of potent antimalarials and their specific accumulation in infected erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023

Basic biochemical investigations as rationale for the design of original antimalarial drugs. An example of phospholipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.05.023